Publicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (74)

2024

  1. Evaluation of soluble P-selectin as a predictive biomarker in acute symptomatic pulmonary embolism: Insights from a prospective observational study

    European Journal of Haematology, Vol. 113, Núm. 2, pp. 201-207

  2. Prognostic Value of D-dimer to Lymphocyte Ratio (DLR) in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients: A Validation Study in a National Cohort

    Viruses, Vol. 16, Núm. 3

  3. Soluble urokinase type plasminogen activator receptor (suPAR) and mortality in acute pulmonary embolism

    Medicina Clinica, Vol. 163, Núm. 6, pp. 281-285

  4. The Potential Role of CA-125 as a Biomarker for Short-Term Mortality Risk in Patients with Acute Symptomatic Pulmonary Embolism

    Journal of Clinical Medicine, Vol. 13, Núm. 12

2023

  1. Atrial Fibrillation and Diabetes Mellitus: Dangerous Liaisons or Innocent Bystanders?

    Journal of Clinical Medicine, Vol. 12, Núm. 8

  2. Micronutrients in Pregnancy after Bariatric Surgery: A Narrative Review

    Journal of Clinical Medicine, Vol. 12, Núm. 16

  3. Visceral extra-abdominal panniculitis after COVID19

    International Journal of Rheumatic Diseases, Vol. 26, Núm. 4, pp. 793-796

2022

  1. Arterial and venous involvement in Behçet’s syndrome: a narrative review

    Journal of Thrombosis and Thrombolysis, Vol. 54, Núm. 1, pp. 162-171

  2. Evaluation of simple laboratory parameters in SARS-CoV-2 infection: the role of ratios

    Infectious Diseases, Vol. 54, Núm. 12, pp. 924-933

  3. Is there sufficient evidence to justify changes in dietary habits in heart failure patients? A systematic review

    Korean Journal of Internal Medicine, Vol. 37, Núm. 1, pp. 37-47

  4. Undertreatment or Overtreatment With Statins: Where Are We?

    Frontiers in Cardiovascular Medicine, Vol. 9

2021

  1. Inflammatory biomarkers in the short-term prognosis of venous thromboembolism: A narrative review

    International Journal of Molecular Sciences, Vol. 22, Núm. 5, pp. 1-14

  2. Long-term follow-up of patients with venous thromboembolism and COVID-19: Analysis of risk factors for death and major bleeding

    European Journal of Haematology, Vol. 106, Núm. 5, pp. 716-723

2020

  1. C-reactive protein level predicts 30-day mortality and bleeding in patients with venous thromboembolism: A prospective single-center study

    Medicina Clinica, Vol. 155, Núm. 2, pp. 51-56

  2. Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels

    Thrombosis Research, Vol. 192, pp. 23-26

  3. Monitoring anti-Xa levels in patients with cancer-associated venous thromboembolism treated with bemiparin

    Clinical and Translational Oncology, Vol. 22, Núm. 8, pp. 1312-1320

  4. Niemann-Pick disease type-B: A unique case report with compound heterozygosity and complicated lipid management

    BMC Medical Genetics, Vol. 21, Núm. 1

  5. Transient ischaemic attack after spacing the dose of alirocumab: Is it advisable to reduce the doses of PCSK9 inhibitors with very low LDL-cholesterols?

    Clinica e Investigacion en Arteriosclerosis, Vol. 32, Núm. 1, pp. 30-32

2019

  1. Effect of pectin on the expression of proteins associated with mitochondrial biogenesis and cell senescence in HT29-human colorectal adenocarcinoma cells

    Preventive Nutrition and Food Science, Vol. 24, Núm. 2, pp. 187-196

  2. Functional analysis of new variants at the low-density lipoprotein receptor associated with familial hypercholesterolemia

    Human Mutation, Vol. 40, Núm. 8, pp. 1181-1190